TABLE 5.
GO term | Pa | No. of regulated genesb | Background frequencyc | Regulation of KTY31 vs KTY3 | Gene name (open reading frame no.) |
---|---|---|---|---|---|
Transport | 0.3 | 54 | 687 | ||
Ion transport | 1.09E-05 | 19 | 90 | ||
Metal ion transport | 1.08E-04 | 11 | 57 | Up | CFL2 (orf19.1264), CTR1 (orf19.3646), FTR1 (orf19.7219), CRP1 (orf19.4784), orf19.2006.1, FET3 (orf19.4211), FET34 (orf19.1206), COX19 (orf19.4967), CFL5 (orf19.1930), FTR2 (orf19.7231), ATX1 (orf19.2369.1) |
2 | Down | orf19.4940, ENA21 (orf19.5170) | |||
Other | 4 | Up | PHO87 (orf19.2454), SSU1 (orf19.7313), SUL2 (orf19.2738), MEP1 (orf19.1614) | ||
2 | Down | orf19.2959.1, PHO84 (orf19.1172) | |||
Lipid transport | 4.56E-04 | 1 | 16 | Up | orf19.4342 |
5 | Down | RTA2 (orf19.24), GIT2 (orf19.1978), RTA3 (orf19.23), GIT1 (orf19.1979), orf19.34 | |||
Oligopeptide transport | 7.94E-04 | 5 | 12 | Down | OPT4 (orf19.176), PTR2 (orf19.6937), IFC3 (orf19.3749), OPT9 (orf19.2584), OPT1 (orf19.2602) |
Vitamin transport | 1.21E-03 | 1 | 4 | Up | TNA1 (orf19.4335) |
2 | Down | PHO113 (orf19.2619), PHO112 (orf19.3727) | |||
Basic amino acid transport | 9.08E-03 | 1 | 7 | Up | CAN2 (orf19.111) |
2 | Down | ALP1 (orf19.2337), orf19.4940 |
That is, the significance of overrepresentation of the listed GO terms comparing the transcriptional profiles of strains KTY31 to KTY3 in the presence of doxycycline.
That is, the number of differentially regulated genes belonging to the listed GO terms.
That is, the number of genes belonging to the listed GO terms on a genome-wide level.